Fosun Pharma (02196.HK / 600196.SH) Releases November 2025 Monthly Return on Movements in Securities

Bulletin Express12-02

On 2 December 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. published its monthly return for the period ended 30 November 2025, reporting an authorized share capital of RMB 2,670,429,325. This total consists of 551,940,500 H shares and 2,118,488,825 A shares, each with a par value of RMB 1.

The number of issued H shares remains 540,971,500 (excluding 10,969,000 treasury shares), and the number of issued A shares remains 2,098,582,573 (excluding 19,906,252 treasury shares). No changes were recorded in share capital or treasury shares during November. Under the 2025 A Share Option Scheme, 4,535,100 A Share Options were granted on 4 November 2025, and 10,589,500 H Share Restricted Share Units were granted under the 2025 H Share RSU Scheme. Neither program led to any new issuance of shares or transfers from treasury shares in November.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1166932900?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 16:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166932900","market":"us","top_or_hot":-1,"title":"Fosun Pharma (02196.HK / 600196.SH) Releases November 2025 Monthly Return on Movements in Securities","media":"Bulletin Express","content":"<p>On 2 December 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. published its monthly return for the period ended 30 November 2025, reporting an authorized share capital of RMB 2,670,429,325. This total consists of 551,940,500 H shares and 2,118,488,825 A shares, each with a par value of RMB 1.</p>\n<p>The number of issued H shares remains 540,971,500 (excluding 10,969,000 treasury shares), and the number of issued A shares remains 2,098,582,573 (excluding 19,906,252 treasury shares). No changes were recorded in share capital or treasury shares during November. Under the 2025 A Share Option Scheme, 4,535,100 A Share Options were granted on 4 November 2025, and 10,589,500 H Share Restricted Share Units were granted under the 2025 H Share RSU Scheme. Neither program led to any new issuance of shares or transfers from treasury shares in November.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fosun Pharma (02196.HK / 600196.SH) Releases November 2025 Monthly Return on Movements in Securities</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFosun Pharma (02196.HK / 600196.SH) Releases November 2025 Monthly Return on Movements in Securities\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-02 16:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 2 December 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. published its monthly return for the period ended 30 November 2025, reporting an authorized share capital of RMB 2,670,429,325. This total consists of 551,940,500 H shares and 2,118,488,825 A shares, each with a par value of RMB 1.</p>\n<p>The number of issued H shares remains 540,971,500 (excluding 10,969,000 treasury shares), and the number of issued A shares remains 2,098,582,573 (excluding 19,906,252 treasury shares). No changes were recorded in share capital or treasury shares during November. Under the 2025 A Share Option Scheme, 4,535,100 A Share Options were granted on 4 November 2025, and 10,589,500 H Share Restricted Share Units were granted under the 2025 H Share RSU Scheme. Neither program led to any new issuance of shares or transfers from treasury shares in November.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"复星医药","start_time":0,"source_url":"","article_id":"1166932900","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166932900","pubTimestamp":1764665424,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 2 December 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. published its monthly return for the period ended 30 November 2025, reporting an authorized share capital of RMB 2,670,429,325....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02196":"复星医药"},"translate_title":"复星医药(02196.HK/600196.SH)发布2025年11月证券变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02196":1},"content_text":"On 2 December 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. published its monthly return for the period ended 30 November 2025, reporting an authorized share capital of RMB 2,670,429,325. This total consists of 551,940,500 H shares and 2,118,488,825 A shares, each with a par value of RMB 1.\nThe number of issued H shares remains 540,971,500 (excluding 10,969,000 treasury shares), and the number of issued A shares remains 2,098,582,573 (excluding 19,906,252 treasury shares). No changes were recorded in share capital or treasury shares during November. Under the 2025 A Share Option Scheme, 4,535,100 A Share Options were granted on 4 November 2025, and 10,589,500 H Share Restricted Share Units were granted under the 2025 H Share RSU Scheme. Neither program led to any new issuance of shares or transfers from treasury shares in November.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1166932900","isCrawlerRequest":true}